Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab
Clinical trial NCT02627924 · COMPLETED
Trial details
- NCT number
- NCT02627924
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-18
- Primary completion
- 2017-12-28
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.